Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA warns doctors, myeloma patients of doubled death risk from AbbVie, Roche's Venclexta

fiercepharmaMarch 23, 2019

Tag: FDA , doubled death , AbbVie

PharmaSources Customer Service